Zsolt Ötvös

Title: Zsolt Ötvös: Innovator in Pharmaceutical Complexes

Introduction

Zsolt Ötvös is a notable inventor based in Csongrád, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug complexes that enhance the efficacy and safety of treatments. With a total of 9 patents to his name, Ötvös has established himself as a key figure in pharmaceutical innovation.

Latest Patents

Ötvös's latest patents include groundbreaking work on complexes of Celecoxib and its salts and derivatives. These complexes are designed to provide stable formulations with controlled particle size, increased apparent solubility, and enhanced dissolution rates. This innovation is particularly beneficial for treating conditions such as osteoarthritis, rheumatoid arthritis, and acute pain, especially in cancer-related cases. The complexes offer instantaneous redispersibility and improved permeability, leading to faster pain relief and reduced gastrointestinal side effects.

Another significant patent involves complexes of Abiraterone acetate. This work focuses on creating pharmaceutically acceptable complex formulations that improve physicochemical properties, resulting in a reduced food effect. This advancement allows for significant dose reductions and eliminates the need for patients to take the medication on an empty stomach.

Career Highlights

Throughout his career, Zsolt Ötvös has worked with various companies, including Druggability Technologies IP Holdco Limited and Nangenex Nanotechnology Incorporated. His work has been instrumental in advancing pharmaceutical technologies and improving patient outcomes.

Collaborations

Ötvös has collaborated with notable professionals in the field, including Genovéva Filipcsei and Tamás Jordán. These partnerships have contributed to the successful development of his innovative pharmaceutical complexes.

Conclusion

Zsolt Ötvös is a distinguished inventor whose work in pharmaceutical complexes has the potential to transform treatment protocols for various medical conditions. His contributions continue to pave the way for advancements in drug formulation and patient care.